New changes to Medicaid and ACA Marketplace may affect many low- and middle-income workers in volatile jobs who have limited access to employment-based health insurance. In the 46 years since Dolly Parton…




New changes to Medicaid and ACA Marketplace may affect many low- and middle-income workers in volatile jobs who have limited access to employment-based health insurance. In the 46 years since Dolly Parton…


Pioneering initiative will generate data at the frontier of healthcare to help transform early biological signals into new opportunities for prevention, diagnosis and treatment. Mayo Clinic today announced the launch of Precure,…
Fatal drug overdoses have long been the focus of the nation’s overdose crisis, but non-fatal overdoses occur far more frequently. These events often bring people to emergency departments, creating opportunities to connect…
A study of over 1,000 U.S. Marines reveals that the natural anti-NMDAR1 antibody may protect the brain following TBI, opening new doors for identifying at-risk patients and developing interventions. Every year, an…


In a study analyzing nearly 3,000 brain MRI exams, researchers found that living in highly disadvantaged neighborhoods was associated with adverse brain health. Results of the study were published today in Radiology. “We’ve long suspected…


Harvard, NYU, and NEJM researchers draw on traffic engineering to explain why more physicians per capita is linked to longer waits . A new analysis published in NEJM Catalyst Innovations in Care Delivery finds…


3D-structure of protein in action reveals clues to its function, could inform future development of cancer treatments A new 3D-structure of a cancer-linked protein bound to its cellular partner reveals details of…


A federal judge in July gave digital equity advocates a partial victory against President Donald Trump, stopping his attempt to unilaterally kill a multibillion-dollar grant program Congress created. But U.S. District…


Preclinical studies demonstrate measurable systemic semaglutide exposure following oral administration; granted claims cover semaglutide and multiple GLP-1 receptor agonists. BioLife today announced that the United States Patent and Trademark Office has granted U.S.…